High-Sensitivity Simultaneous Analysis of Chiral Amino Acids in 10 Minutes without Derivatization Release of the LC/MS/MS Method Package for D/L Amino Acids Contributing to Various Fields Such as Fermented Foods, Clinical and Antiaging Research

The 20 amino acids that form the structure of proteins exist as mirror image optical isomers: the D-amino acids (D-form) and the L-amino acids (L-form) (chiral amino acids)*1). The L-form of amino acids exists in large quantities in foods and in the body as the structural elements of proteins and as nutritional sources. As food... Read more

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

HERCULES, Calif. — June 12, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex® 2200 Syphilis Total & RPR assay, a novel one-step universal testing method to aid in the diagnosis of... Read more

The future of laboratory services revealed at EuroMedLab 2017: The B…

Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields   Forgot your password? Please provide the email address and your last name associated... Read more

Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare

MILWAUKEE – June 9, 2017 – Demand for quality used parts has increased as hospitals and healthcare systems have become more sophisticated about medical equipment maintenance and management. Now more than 10,000 types of refurbished parts for GE Diagnostic Imaging equipment are available as GoldSeal parts from GE Healthcare. Hospital in-house service departments can find... Read more

QIAGEN’s QuantiFERON®-TB Gold Plus gains U.S. FDA approval

Fourth generation Latent TB blood test combines breakthrough CD4/CD8 design for comprehensive immune response detection with the most flexible blood collection workflow Germantown, Maryland, and Hilden, Germany, June 8, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) the fourth generation of the market... Read more

QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform

High-throughput application of artus CMV QS-RGQ MDx Kit on QIAsymphony streamlines critical and frequently performed viral infection test for transplant patients Germantown, Maryland, and Hilden, Germany, June 6, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for its automated... Read more